Community-based cardiovascular disease prevention to reduce cardiometabolic risk in latina women: A pilot program

Journal of Women's Health

Volumn 23, Issue 4, 2014, Pages 350-357

  Altman, Robin ^a   Nunez De Ybarra, Jessica ^a   Villablanca, Amparo C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 12; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMMUNITY CARE; EDUCATION PROGRAM; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HEART INFARCTION; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK REDUCTION; SELF EVALUATION; SMOKING; SODIUM INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMMUNITY-BASED PARTICIPATORY RESEARCH; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PREVALENCE; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; YOUNG ADULT;

EID: 84897978604     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4570     Document Type: Article

References (44)

1. Gulati M, Shaw LJ, Bairey Merz CN. Myocardial ischemia in women: Lessons from the NHLBI WISE study. Clin Cardiol 2012;35:141-148.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011;123:e18-e209.
3. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013;127:e6-e245.
4. Office of Minority Health, US Department of Health and Human Services. Hispanic/Latino profile. 2009. Available at: http://minorityhealth.hhs.gov/ templates/browse.aspx? lvl = 2&lvlD = 54 Accessed December 15, 2013.
5. Davidson JA, Moreno PR, Badimon JJ, et al. Cardiovascular disease prevention and care in Latino and Hispanic subjects. Endocr Pract 2007;13:77-85.
6. Daviglus Ml, Talavera GA, Avilés-Santa ML, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012; 308:1775-1784.
7. Juarbe TC. Risk factors for cardiovascular disease in Latina women. Prog Cardiovasc Nurs 1998;13:17-27.
8. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996;125:221-232.
9. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care 1991;14:628-638.
10. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. Adults. The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes care 1998;21:518-524.
11. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 2009;5:1-7.
12. Liao Y, Bang D, Cosgrove S, et al. Surveillance of health status in minority communities-racial and ethnic approaches to community health across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009. MMWR Surveill Summ 2011;60:1-44.
13. NIH. National Heart, Lung, and Blood Institute Task Force report on research in prevention of cardiovascular disease 2001;2013. Available at: https://www.nhlbi.nih.gov/...cvdrpt .htm Accessed December 15, 2013.
14. Grady D, Chaput L, Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women: Summary. AHRQ Evidence Report Summaries 2003;1-4. Available at: http://www.ncbi.nlm.nih.gov/ books1NBK119119/Accessed December 15, 2013.
15. Flink LE, Sciacca RR, Bier ML, Rodriguez J, Giardina EG. Women at risk for cardiovascular disease lack knowledge of heart attack symptoms. Clin Cardiol 2013;36:133-138.
16. Padilla R, Bull S, Raghunath SG, Fernald D, Havranek EP, Steiner JF. Designing a cardiovascular disease prevention web site for Latinos: Qualitative community feedback. Health Promot Pract 2010;11:140-147.
17. DuBard CA, Garrett J, Gizlice Z. Effect of language on heart attack and stroke awareness among U.S. Hispanics. Am J Prev Medicine 2006;30:189-196.
18. Aranda JM, Jr., Vazquez R. Awareness of hypertension and diabetes in the Hispanic community. Clin Cornerstone 2004;6:7-13; discussion, 14-15.
19. CDC. Missed opportunities in preventive counseling for cardiovascular disease-United States, 1995. MMWR Weekly 1998;47:91-95.
20. Ferris A, Robertson RM, Fabunmi R, Mosca L. American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation 2005;111:1321-1326.
21. Krummel DA, Koffman DM, Bronner Y, et al. Cardiovascular health interventions in women: What works? J Womens Health Gend Based Med 2001;10:117-136.
22. Lasco RA, Curry RH, Dickson VJ, Powers J, Menes S, Merritt RK. Participation rates, weight loss, and blood pressure changes among obese women in a nutritionexercise program. Public Health Rep 1989;104:640-646.
23. Yanek LR, Becker DM, Moy TF, Gittelsohn J, Koffman DM. Project Joy: Faith based cardiovascular health promotion for African American women. Public Health Rep 2001;116 Suppl 1:68-81.
24. Farquhar JW, Fortmann SP, Flora JA, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA 1990;264:359-365.
25. Villablanca AC, Arline S, Lewis J, Raju S, Sanders S, Carrow S. Outcomes of national community organization cardiovascular prevention programs for high-risk women. J Cardiovasc Transl Res 2009;2:306-320.
26. Villablanca AC, Beckett LA, Li Y, et al. Outcomes of comprehensive heart care programs in high-risk women. J Womens Health (Larchmt) 2010;19:1313-1325.
27. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 2010;127:295-314.
28. Mitra B, Panja M. High sensitive C-reactive protein: A novel biochemical markers and its role in coronary artery disease. Journal Assoc Physicians India 2005;53:25-32.
29. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
30. Fearon WF, Fearon DT. Inflammation and cardiovascular disease: Role of the interleukin-1 receptor antagonist. Circulation 2008;117:2577-2579.
31. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12:204-212.
32. Kirchberger I, Heier M, Kuch B, Wende R, Meisinger C. Sex differences in patient-reported symptoms associated with myocardial infarction (from the population-based MONICA/KORA Myocardial Infarction Registry). Am J Cardiol 2011;107:1585-1589.
33. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation 2011;123:1243-1262.
34. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An Aamerican Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive summary. Circulation 2005;112:e285-e290.
35. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: Results of a 2012 American Heart Association national survey. Circulation 2013;127:1254-1263.
36. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. Adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007;55:1056-1065.
37. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233-1241.
38. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
39. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168:1617-1624.
40. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
41. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
42. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010;17:1-11.
43. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-2610.
44. Zhang SX, Guo HW, Wan WT, Xue K. Nutrition education guided by Dietary Guidelines for Chinese Residents on metabolic syndrome characteristics, adipokines and inflammatory markers. Asia Pac J Clin Nutr 2011;20:77-86.